Results 221 to 230 of about 42,192 (230)

Harnessing chimeric antigen receptor macrophages against solid tumors

open access: yesCancer Communications, EarlyView.
Abstract Macrophages are prevalent in multiple tumors and exhibit diverse and potent functional activities. Therapeutic reprogramming of macrophage phenotypes represents a promising strategy for cancer immunotherapy. Engineering chimeric antigen receptors (CARs) to endow macrophages with anti‐tumor capacities demonstrated encouraging efficacy ...
Mengru Wang   +3 more
wiley   +1 more source

Mesenteric cystic lymphangioma in three adults. [PDF]

open access: yesJ Surg Case Rep
Boujguenna I   +4 more
europepmc   +1 more source

Model‐Informed Drug Development Applications and Opportunities in mRNA‐LNP Therapeutics

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
The utilization of lipid nanoparticles (LNP) for encapsulating mRNA has revolutionized the field of therapeutics, enabling the rapid development of COVID‐19 vaccines and cancer vaccines. However, the clinical development of mRNA‐LNP therapeutics faces numerous challenges due to their complex mechanisms of action and limited clinical experience.
Jiawei Zhou   +6 more
wiley   +1 more source

Cutaneous Lymphangioma Circumscriptum. [PDF]

open access: yesDermatol Pract Concept
Lei X, Bian K, Xie B.
europepmc   +1 more source

Mast cell modulation of the vascular and lymphatic endothelium.

open access: yesBlood, 2011
Kunder CA, St John AL, Abraham SN.
europepmc   +1 more source

Genetic lineage tracing identifies intermediate mesoderm as a novel contributor to mammalian kidney lymphatics

open access: yes
Jafree DJ   +20 more
europepmc   +1 more source

Uncovering the transcriptional hallmarks of endothelial cell aging via integrated single-cell analysis

open access: yes
Dobner S   +22 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy